Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study
about
Aspirin intake and survival after breast cancerImmunity, Inflammation, and CancerUse of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) studyCyclooxygenase-2 and the inflammogenesis of breast cancer.Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.Analgesic use and sex steroid hormone concentrations in postmenopausal women.Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyUse of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women.Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study.Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis.Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study.Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer.Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidenceModulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer.Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women.Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal womenMigraine in postmenopausal women and the risk of invasive breast cancerRegular aspirin use and breast cancer risk in US Black women.Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial.Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis.Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives.Systemic Levels of Estrogens and PGE2 Synthesis in Relation to Postmenopausal Breast Cancer Risk.The role of dendritic cells in cancer.Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients.Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours.Aspirin use and breast cancer risk: a meta-analysis.Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota.Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour.
P2860
Q24604280-3CEDFEC1-E43E-46EF-A2D0-EFB7746C5857Q27861048-0537C29B-7475-4FCA-916F-92AD85C590FAQ28597617-7297A380-5C68-4740-8060-D3B79B831DBBQ30367680-D0B4E57D-D03B-48EA-917B-BF68A1B7CBB6Q33619700-281DA03B-5E4D-4989-B9E0-8345F259FE43Q33780860-988086F6-AF29-4432-BC76-17E30B2F1D2BQ33889458-1F2975CC-1056-4F4A-BAC4-AE66C9CC486BQ34034263-288D30A4-A5F0-4F24-BB99-D1174344C8F9Q34069337-C8AE4F23-E7CF-457A-9897-BA9E0233111DQ34381496-3CD478F3-6498-4762-B06B-2FC3A128E8BFQ34458235-7F4B0861-7BB5-4D1F-91F3-7B43D7735264Q35227086-3BEBFF91-A0B4-4008-8D4C-4CFD7AB7861EQ35648998-A74DA7D7-D48A-45EC-9676-DCE3F1466726Q35711979-C164EAF6-B260-44CE-A24B-F9E3A3544E78Q35870384-33EFAEB8-8592-420B-BA42-B7A4DEE52731Q36099670-844E2B29-C783-4928-B931-CECDAB9E3C02Q36134167-53D3B5D2-ED47-48E1-B4F5-22FFAABDB252Q36267669-E5A42A05-2195-40AB-9FFB-55CEC8484587Q36393212-0A76207C-15AD-456D-B918-F95C143804F2Q36689177-236C407B-E39F-4A59-8B9C-F561121BF0EEQ36727026-68DB1709-250A-494C-A92E-5847FCD1FB10Q36806255-4B193240-1913-4D0D-92F4-1A4FB83A139AQ36824033-72581008-9B17-40E7-ACF4-D9F007E139B0Q37216584-B70592A2-95D7-4B9C-AACC-B2A9A83D5B59Q37324216-C7DA0DE3-3879-4274-8C27-092B915709BDQ37712766-573A5918-88CE-474E-89DA-2CCA5A3452FDQ38025038-70EDA3DB-9092-4881-8225-97F9E1FE07DBQ38551802-6F2E97A0-41CB-4261-9468-75784F776573Q38786791-01ED37E1-1F77-4DB4-B252-794A2E8363A1Q38793447-3F6B036B-69FF-451F-A058-BF695C3E9153Q38957065-9C612586-A953-4974-95FB-2C95D8420AC7Q39049128-17D80E42-C781-4483-8197-D1660D41D230Q39489175-660C128F-1027-4759-A433-A5B819D002ACQ39710075-77714CF7-6ACD-4FB3-BE50-D96437856D56Q41093416-BB4AC19E-9CC3-47FA-9A79-EBF018E691C4Q41420993-BA986804-9CA4-4AEC-AB4A-4560BB827CE9Q43061636-A7CDF978-FD96-4B3A-93FE-BC798CE811B4Q50155271-C71873A2-E517-4004-8384-A3D5A9E41DBEQ51382532-9EA09B08-131B-4961-9DD5-C9300BCE2817Q54970116-91EB434B-5473-4118-B30B-B40C84828314
P2860
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Nonsteroidal anti-inflammatory ...... lth-AARP Diet and Health Study
@ast
Nonsteroidal anti-inflammatory ...... lth-AARP Diet and Health Study
@en
type
label
Nonsteroidal anti-inflammatory ...... lth-AARP Diet and Health Study
@ast
Nonsteroidal anti-inflammatory ...... lth-AARP Diet and Health Study
@en
prefLabel
Nonsteroidal anti-inflammatory ...... lth-AARP Diet and Health Study
@ast
Nonsteroidal anti-inflammatory ...... lth-AARP Diet and Health Study
@en
P2093
P2860
P50
P356
P1476
Nonsteroidal anti-inflammatory ...... lth-AARP Diet and Health Study
@en
P2093
Albert R Hollenbeck
Douglas Richesson
Gretchen L Gierach
James V Lacey
P2860
P2888
P356
10.1186/BCR2089
P577
2008-04-30T00:00:00Z
P5875
P6179
1014046199